weight loss drug prescriptions semaglutide tirzepatide q3 2024 Between 2021 and 2024, and in Epic-affiliated health care systems increased slightly but remained limited, with only 3% of eligible patients receiving them. https://ja.ma/4ng5422 Shortages improve for Lilly's GLP-1

The FDA prescribing information includes a boxed warning for thyroid C-cell tumors and notes that tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis

If more fat is being efficiently converted to fuel, there is less metabolic pressure to cannibalize muscle tissue

Buyer takeaway: you're never charged for months after you cancel, only the difference on months you already received

The APC said in an email to clients over the weekend that its working with lawyers to get clarity on whether the FDAs new filing means that it will not take enforcement against all compounding pharmacies who make tirzepatide or just the plaintiffs in the lawsuit

But without stability data, there is also no way to quantify exactly how much potency has been lost